The purpose of this study is to evaluate the performance of the Agili-CTM implant in the treatment of osteoarthritis of the Great Toe.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years or older
* Osteoarthritis of the First Metatarsophalangeal Joint
* Presence of good bone stock
* Physically and mentally willing and able to comply with post-operative
* rehabilitation and routinely scheduled clinical and radiographic visits
Exclusion Criteria:
* \< 18 years of age
* Any past or present evidence of infection of the treated joint
* Any known malignant tumor of the foot
* Known inflammatory arthropathy or crystal-deposition arthropathy
* Chemotherapy treatment in the past 12 months
* History of allergic reaction or intolerance to calcium carbonate or hyaluronate
* Patient who is pregnant or intends to become pregnant during the study
* History of any significant systemic disease, such as but not limited to, HIV infection, hepatitis infection or HTLV infection; known coagulopathies, that might compromise the subject's welfare
* Known substance abuse or alcohol abuse
* Participation in other clinical trials in parallel to this study
* Known insulin dependent diabetes mellitus
* Unable to undergo imaging studies